Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113667006B reveals a novel liquid-phase route for Semaglutide intermediates offering high purity and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN119285532B reveals a novel five-step synthesis route offering cost reduction and scalable production for high-purity pharmaceutical intermediates.
Patent CN107793351A reveals advanced C-H amination for beta amino acids. Enables cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains globally.
Patent CN103044238A reveals a mild, high-yield route for calcium 3-methyl-2-oxovalerate, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Discover the patented purification method for Chlorin e6 achieving >99% purity. A scalable, cost-effective solution for photodynamic therapy intermediates.
Patent CN110343087B details a cobalt-catalyzed C-H activation method for isoindolinone derivatives, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Novel copper complex synthesis offers enhanced antitumor activity and scalable manufacturing processes for global pharmaceutical supply chains.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Novel electrochemical method for 2-phenylpropionic acid using DMC and Mg. High purity, mild conditions, green solvent system for loxoprofen sodium production.
Novel rearrangement method for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability via patent CN108409602A.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Novel copper-catalyzed route for 2-azabicyclo[3.2.0] intermediates offers mild conditions and high yields, ensuring reliable supply chain solutions.
Patent CN105384809B reveals a segment solid-liquid method improving purity and reducing steps for Teriparatide manufacturing, offering supply chain stability.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.
Patent CN1036712C discloses an efficient route for carbocyclic purine antiviral agents. This report analyzes the cost-effective salt-mediated alkylation process for pharmaceutical manufacturing.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN107793351B details a novel Pd-catalyzed route to diverse beta-amino acids, offering mild conditions and structural variety for API intermediate manufacturing.
Novel photocatalytic route offers high purity and green manufacturing advantages for pharmaceutical intermediates supply chains globally.
Patent CN103709164A details a cost-effective adenine synthesis using malononitrile, offering high purity and reduced waste for pharmaceutical manufacturing.